27121/34347US=1-B / Farmacologia
Petri WA Jr. Penicillins, cephalosporins, and other b-lactam antibiotics. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1127-1154. ISBN 978-0-071-142280-3.

PENICILINAS; CEFALOSPORINAS; ANTIBIOTICOS B-LACTAMICOS; INIBIDORES DA B-LACTAMASE


27122/34347US=1-B / Farmacologia
Chambers HF. Aminoglycosides. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1155-71. ISBN 978-0-071-142280-3.

AMINOGLICOSIDEOS; AMINOGLICOSIDEOS, FEITOS ADVERSOS; ESTREPTOMICINA; GENTAMICINA; TOBRAMICINA; AMICACINA; NETILMICINA; CANAMICINA; NEOMICINA


27123/34347US=2 / Biol/Mol
Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS


27124/34347US=2 / Biol/Mol
Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA


27125/34347US=2 / Biol/Mol
Micheau O. Death receptor: cellular FLICE-inhibitory protein: an update. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 120-56. ISBN 978-3-527-31237-5.

CANCER; RECEPTOR MORTE; PROTEINA INIBITORIA DA FLICE; GENE FLIP


27126/34347US=1-B / Farmacologia
Chambers HF. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1173-202. ISBN 978-0-071-142280-3.

INIBIDORES DA SINTESE DE PROTEINAS; AGENTES ANTIBACTERIANOS VARIADO; TETRACICLINAS; CLORANFENICOL; MACROLIDEOS; QUETOLIDOS; TELITROMICINA; CLINDAMICINA; QUINUPRISTIN; DALFOPRISTIN; LINEZOLIDA; VANCOMICINA


27127/34347US=2 / Biol/Mol
Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE


27128/34347US=1-B / Farmacologia
Petri WA Jr. Chemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1203-23. ISBN 978-0-071-142280-3.

QUIMIOTERAPIA DA TUBERCULOSE; DOENCA DE COMPLEXO DE MYCOBACTERIUM AVIUM; LEPRA; DROGAS PARA A TUBERCULOSE; DROGAS PARA A LEPRA


27129/34347US=2 / Biol/Mol
Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5.

APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C


27130/34347US=2 / Biol/Mol
Suzuki Y, Takahashi R. Mitochondria: omi/HtrA2: a mitochondrial serine protease regulating cellular life and death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 222-32. ISBN 978-3-527-31237-5.

MITOCONDRIAS; OMI/HTRA2; SERINA PROTEASE MITOCONDRIAL; MORTE CELULAR


27131/34347US=1-B / Farmacologia
Bennett JE. Antimicrobial agentes: antifungal agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1225-41. ISBN 978-0-071-142280-3.

AGENTES ANTIMICROBIANOS; AGENTES ANTIFUNGICOS; ANTIFUNGICOS SISTEMICOS


27132/34347US=2 / Biol/Mol
Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5.

MITOCONDRIAS; FATOR DE INDUCAO DE APOPTOSE; ISOFORMES


27133/34347US=2 / Biol/Mol
Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; CASPASES; APOPTOSE


27134/34347US=1-B / Farmacologia
Hayden FG. Antiviral agentes (nonretroviral). In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1242-71. ISBN 978-0-071-142280-3.

AGENTES ANTIVIRAIS; NAO RETROVIRAL; AGENTES ANTIHERPESVIRUS; AGENTES ANTI-GRIPE; AGENTES ANTIHEPATITIS


27135/34347US=2 / Biol/Mol
Cain K. Effector systems: the role of the apoptosome and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 282-313. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; TERAPIA APOPTOSSOMO; CANCER; CITOCROMO C; CASPASE


27136/34347US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE


27137/34347US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER


27138/34347US=1-B / Farmacologia
Flexner C. Antiretroviral agents and treatment of HIV infection. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1273-1314. ISBN 978-0-071-142280-3.

AGENTES DE TRATAMENTO; INFECCAO POR HIV ANTI-RETROVIRAIS; HISTORIA DA TERAPIA ANTI-RETROVIRAL; QUIMIOTERAPIA DO HIV; NUCLEOSIDEOS; INIBIDORES DA TRANSCRIPTASE REVENSE NUCLEOTIDOS; INIBIDORES NAO-NUCLEOSIDEOS DA TRANSCRIPTASE REVERSA; INIBIDORES DA PROTEASE DO HIV; INIBIDORES DE ENTRADA


27139/34347US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR


27140/34347US=2 / Biol/Mol
Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5.

IAPS; INIBIDORES DE PROTEINAS DE APOPTOSE


Primeira | Anterior | Próxima | Última